Spermosens AB (publ) (NGM:SPERM)
Sweden · Delayed Price · Currency is SEK 0.0090
0.00 (0.00%)
At close: Sep 3, 2026
Spermosens AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.88 | 6.84 | 0.66 | 4.49 | 0.55 | 6.69 |
Cash & Short-Term Investments | 1.88 | 6.84 | 0.66 | 4.49 | 0.55 | 6.69 |
Cash Growth | -84.11% | 937.33% | -85.33% | 713.77% | -91.75% | 80.35% |
Other Receivables | 0.83 | 0.97 | 1.09 | 0.99 | 0.56 | 0.61 |
Receivables | 0.83 | 0.97 | 1.09 | 0.99 | 0.56 | 0.61 |
Prepaid Expenses | - | - | 0.01 | 0.23 | 0.26 | 0.09 |
Other Current Assets | - | - | -0 | - | - | - |
Total Current Assets | 2.71 | 7.8 | 1.76 | 5.72 | 1.37 | 7.4 |
Property, Plant & Equipment | 0.23 | 0.32 | 0.46 | 0.65 | 0.71 | - |
Long-Term Deferred Charges | - | 25.82 | 24.34 | 19.74 | 7.58 | 18.28 |
Other Long-Term Assets | - | - | 4.49 | - | - | - |
Total Assets | 28.92 | 33.94 | 31.04 | 26.11 | 9.66 | 25.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.55 | 0.13 | 2.02 | 1.34 | 0.74 | 0.48 |
Accrued Expenses | - | 0.73 | 0.78 | 1.44 | 1.23 | 0.73 |
Short-Term Debt | - | - | 0.23 | 9.29 | 0.13 | 0.13 |
Current Unearned Revenue | - | - | - | - | - | 0.18 |
Other Current Liabilities | - | 0.67 | 0.67 | 1.12 | 0.51 | 0.16 |
Total Current Liabilities | 0.55 | 1.53 | 3.7 | 13.18 | 2.6 | 1.68 |
Long-Term Debt | - | - | - | 0.23 | 1.24 | 0.37 |
Other Long-Term Liabilities | 0.91 | - | -0 | - | - | - |
Total Liabilities | 1.47 | 1.53 | 3.7 | 13.41 | 3.84 | 2.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 27.45 | 6.35 | 1.52 | 4.12 | 1.21 | 1.05 |
Additional Paid-In Capital | - | 102.5 | 92.17 | 65.61 | 49.45 | 31.04 |
Retained Earnings | - | -76.44 | -67.24 | -57.03 | -44.83 | -8.45 |
Comprehensive Income & Other | - | - | 0.9 | - | - | - |
Shareholders' Equity | 27.45 | 32.41 | 27.35 | 12.69 | 5.83 | 23.64 |
Total Liabilities & Equity | 28.92 | 33.94 | 31.04 | 26.11 | 9.66 | 25.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | 0.23 | 9.52 | 1.36 | 0.49 |
Net Cash (Debt) | 1.88 | 6.84 | 0.43 | -5.03 | -0.81 | 6.2 |
Net Cash Growth | -84.11% | 1493.47% | - | - | - | - |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | -0.13 | -0.07 | 0.70 |
Filing Date Shares Outstanding | 173.02 | 3,173 | 283.61 | 41.19 | 12.12 | 10.51 |
Total Common Shares Outstanding | 173.02 | 3,173 | 283.61 | 41.19 | 12.12 | 10.51 |
Working Capital | 2.16 | 6.27 | -1.94 | -7.47 | -1.23 | 5.72 |
Book Value Per Share | 0.16 | 0.01 | 0.10 | 0.31 | 0.48 | 2.25 |
Tangible Book Value | 1.47 | 32.41 | 27.35 | 12.69 | 5.83 | 23.64 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.10 | 0.31 | 0.48 | 2.25 |
Machinery | - | 0.88 | 0.86 | 0.89 | 0.78 | - |